Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

Similar articles for PubMed (Select 11968802)

1.

[Impact of a clinical pathway in cases of transurethral resection of the prostate].

Aizawa T, Kin T, Kitsukawa S, Mamiya Y, Akiyama A, Ohno Y, Okubo Y, Miki M, Tachibana M.

Nihon Hinyokika Gakkai Zasshi. 2002 Mar;93(3):463-8. Japanese.

2.

[Implementation of a common clinical path for transurethral resection of prostate (TURP) in multiple hospitals].

Okamura K, Ozawa H, Kinukawa T, Imamura M, Saito S, Terai A, Takei M, Hasegawa T.

Nihon Hinyokika Gakkai Zasshi. 2004 Nov;95(7):792-9. Japanese.

3.

Impact of a clinical pathway in cases of transurethral resection of the prostate.

Nagata Y, Masuda A, Suzuki Y.

Tokai J Exp Clin Med. 2007 Jul 20;32(2):54-8.

4.

[Economic evaluation of treatment for benign prostatic hyperplasia--transurethral resection vs thermotherapy vs laser vaporization].

Aizawa T, Mamiya Y, Namiki K, Okubo Y, Kim T, Arai Y, Ito T, Miki M, Tachibana M.

Nihon Hinyokika Gakkai Zasshi. 2002 Nov;93(7):736-42. Japanese.

5.
7.

A cost-minimisation analysis comparing photoselective vaporisation (PVP) and transurethral resection of the prostate (TURP) for the management of symptomatic benign prostatic hyperplasia (BPH) in Queensland, Australia.

Whitty JA, Crosland P, Hewson K, Narula R, Nathan TR, Campbell PA, Keller A, Scuffham PA.

BJU Int. 2014 Mar;113 Suppl 2:21-8. doi: 10.1111/bju.12051. Epub 2013 Apr 10.

PMID:
23574626
8.
9.

Transurethral resection vs microwave thermotherapy of the prostate: a cost-consequences analysis.

De La Rosette JJ, Floratos DL, Severens JL, Kiemeney LA, Debruyne FM, Pilar Laguna M.

BJU Int. 2003 Nov;92(7):713-8.

PMID:
14616453
10.

[Clinical studies on TUR-P using clinical path: report of 50 cases and review of literature].

Asano K, Omono H, Sasaki H, Miki J, Naruoka T, Yamada H, Maeda S, Shimomura T, Shiono Y, Sugaya S, Oishi Y.

Nihon Hinyokika Gakkai Zasshi. 2003 Mar;94(3):413-9. Japanese.

11.

[Implementation of a clinical pathway for transurethral resection in benign prostatic hyperplasia].

Sánchez Merino JM, Parra Muntaner L, Gómez Cisneros SC, Monsalve Rodríguez M, Jiménez Rodríguez M, García Alonso J.

Arch Esp Urol. 2002 Mar;55(2):131-44. Spanish.

PMID:
12014045
14.
15.

Cost effectiveness of microwave thermotherapy in patients with benign prostatic hyperplasia: part II--results.

Blute M, Ackerman SJ, Rein AL, Beusterien K, Sullivan EM, Tanio CP, Strauss MJ, Manyak MJ.

Urology. 2000 Dec 20;56(6):981-7.

PMID:
11113744
16.

[Usefulness of an all-in-one clinical pathway for transurethral resection of prostate].

Arisawa C, Yokoyama M, Ohno R, Ando M.

Hinyokika Kiyo. 2005 Mar;51(3):143-9. Japanese.

PMID:
15852665
17.

Trans urethral electric vaporisation of prostate as an alternate to trans urethral resection in benign prostatic hyperplasia.

Akhtar MM, Orakzai N, Qureshi AM.

J Ayub Med Coll Abbottabad. 2004 Oct-Dec;16(4):16-20.

PMID:
15762056
18.
19.

An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia.

DiSantostefano RL, Biddle AK, Lavelle JP.

BJU Int. 2006 May;97(5):1007-16. Epub 2006 Mar 17.

PMID:
16542339
20.

Photoselective laser vaporization prostatectomy versus transurethral prostate resection: a cost analysis.

Goh AC, Gonzalez RR.

J Urol. 2010 Apr;183(4):1469-73. doi: 10.1016/j.juro.2009.12.020. Epub 2010 Feb 20.

PMID:
20172555
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk